Our findings suggest that Cp infection contributes to AD dementia but not initiating pathology, whereas early NLRP3 activation may promote disease development, warranting studies on Cp’s role in AD pathogenesis and early antibiotic or inflammasome-targeted therapies. This evidence concerns the gene NLRP3 and Alzheimer disease.